Related Experiment Video
Updated: Jun 4, 2026

Dynamic Light Scattering Analysis for the Determination of the Particle Size of Iron-Carbohydrate Complexes
Published on: July 7, 2023
Multidisciplinary approach to implementing ferric carboxymaltose for IV iron replacement in heart failure with iron
Marat Fudim1,2, Francesco Ferrante3, Cassandra M Vorgang4
1Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
Insights
Iron deficiency in heart failure patients improves with intravenous iron. This guide offers a workflow to ensure iron repletion and optimize outcomes for heart failure patients with iron deficiency.
Area of Science:
- Cardiology
- Hematology
- Pharmacology
Background:
- Iron deficiency (ID) is a frequent comorbidity in heart failure (HF) patients.
- Intravenous (IV) iron is guideline-recommended to enhance HF symptoms, exercise capacity, quality of life, and reduce hospitalizations.
- Ferric carboxymaltose (FCM) is approved for ID in adults with HF (NYHA class II/III) to improve exercise capacity.
Purpose of the Study:
- To present a general workflow for routine iron assessment and IV iron repletion in HF care pathways.
- To address challenges in achieving iron repletion in routine practice, such as formulary restrictions and care transitions.
- To emphasize a multidisciplinary approach involving cardiologists, nurses, APPs, and pharmacists.
Main Methods:
- The guide outlines a workflow implemented in university-based and private hospital systems.
- It incorporates perspectives from various healthcare professionals (cardiologist, nurse, APP, pharmacist).
- Focuses on facilitating iron assessment and IV iron repletion within a typical HF care pathway.
Main Results:
- The workflow aims to overcome barriers to optimal iron repletion in HF patients.
- It highlights the importance of collaboration among healthcare providers.
- Facilitates consistent iron assessment and treatment delivery.
Conclusions:
- A multidisciplinary, collaborative approach is crucial for optimizing outcomes in HF patients with ID.
- Implementing a structured workflow can improve iron repletion rates and patient benefits.
- Addressing practical challenges ensures eligible patients receive timely and effective IV iron therapy.
Abstract:
Iron deficiency (ID) is a common comorbidity in patients with heart failure (HF). Treatment with intravenous (IV) iron is recommended by the ACC/AHA/HFSA and ESC guidelines to improve HF symptoms, exercise capacity, and quality of life, and to reduce the risk of hospitalization. Ferric carboxymaltose (FCM) is indicated for ID in adults with HF (NYHA class II/III) to improve exercise capacity. There are challenges in ensuring that eligible patients with HF and ID achieve iron repletion and associated optimal outcomes in routine practice. These challenges include inpatient formulary restrictions which only allow for low-dose IV irons and care transitions when the course of IV iron treatment spans the inpatient and outpatient setting. Despite the ease of administration as a single rapid infusion of up to 1000 mg of iron, inpatient and outpatient formularies do not always include FCM. This guide shares a general workflow used at university-based and private hospital systems, to facilitate routine iron assessment and IV iron repletion in a typical HF care pathway. Perspectives from the cardiologist, nurse, advanced practice provider (APP), and pharmacist roles provide a comprehensive view and emphasize the importance of a multidisciplinary, collaborative approach to optimize outcomes for patients with HF and ID.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care
Heart Failure VII: Nursing Interventions
Heart Failure IV: Classification and Diagnostic Evaluation
Mitral Regurgitation IV: Nursing Management
